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1. Introduction 
Liposuction since its beginning has been used primarily for contouring localized deposits of 
fat to give its recipients an improved cosmetic appearance. The most common areas to 
which liposuction techniques have been applied are the abdomen, flank region, thighs, and 
submental neck. Since the advent of the tumescent technique in the late 1980s, including the 
use of local anesthesia and small diameter cannulas, the safety of liposuction has been 
established. Along with safety has come the application of the liposuction technique to 
medical conditions including non-fatty tissues, such as the removal of salivary gland tissue 
in the treatment of axillary hyperhidrosis and the combined glandular and fatty tissue of 
gynecomastia.  
This chapter will examine the application and efficacy of the liposuction technique in 
treating two common and related conditions found in human immunodeficiency virus 
(HIV) positive patients: the dorsocervical fat pad and bilateral parotid hypertrophy in the 
broader context of HIV lipodystrophy. The procedures described herein avoid general 
anesthesia and utilize the awake patient as a participant in the procedure to optimize 
reduction of the hypertrophic tissue. In the case of the dorsocervical fat pad, the positioning 
of the patient in the seated upright position results in a more effective and complete 
suctioning than in the traditional prone position. A bonus is that this position is more 
comfortable for the surgeon, in reducing operating room fatigue. In the case of parotid 
hypertrophy, using an established technique such as liposuction, can be shown to provide 
an excellent reconstructive and cosmetic result while providing a better safety profile than 
other treatment options. Our experience in the use of these procedures indicates that 
patients rate their experience and satisfaction with the procedures as very high. 
Current procedural terminology (CPT) and international classification of disease (ICD) 
codes are provided to improve insurance provider reimbursement for patients. 
2. Lipodystrophy 
Since the advent of highly active antiretroviral therapy (HAART), people with HIV 
infections and acquired immunodeficiency syndrome (AIDS) are living longer and better 
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lives(Taiwo et al. 2010). A side effect attributable to HAART is the development, in some 
patients, of a complex of signs and symptoms collectively referred to as lipodystrophy. HIV 
lipodystrophy is manifested by a constellation of anthropometric changes, including 
lipoatrophy of the face, extremities, and buttocks(Tien and Grunfeld 2004) as well as 
lipohypertrophy in the upper back, commonly called “buffalo hump” or dorsocervical fat 
pad. Fat loss in the face and extremities conveys a falsely cachectic appearance to patients 
who are otherwise healthy. Patients with lipodystrophy also commonly have increased 
abdominal adiposity, chest adiposity, and increased glandular breast tissue, the latter 
known as gynecomastia. While some patients have only lipoatrophy(Grunfeld et al. 2010), 
others over time develop signs and symptoms of  lipohypertrophy as well. Many patients 
have associated internal and metabolic abnormalities such as diabetes, advanced coronary 
disease, and cardiomyopathy.(Carr et al. 1998; Domingo et al. 1999; Safrin and Grunfeld 
1999; Murata et al. 2000; Petit et al. 2000)   
Another less recognized feature of lipodystrophy is bilateral parotid hypertrophy. (Sooy, 
1987) Enlargement of the parotid glands, the largest of the salivary glands, is commonly 
seen in HIV positive patients(Tall et al. 1985) and is often referred to in the HIV community 
as “chipmunk cheeks” as it imparts a fullness to the lateral check area. While HAART is 
often cited as its causation, as with lipodystrophy, its etiology is unknown. 
The first part of this chapter will focus on the lipohypertrophy of the dorsocervical fat pad 
and a novel method of removing it with liposuction under local tumescent anesthesia. The 
second part of this chapter will focus on the removal of the lateral portion of the 
hypertrophied parotid gland in an equally novel but different approach using a technique 
borrowed from liposuction. 
3. Dorsocervical fat pad 
3.1 Background 
The dorsocervical fat pad represents a subcutaneous, non-encapsulated accumulation of 
adipose tissue with a striking fibro-connective tissue component. The authors prefer the 
term “dorsocervical fat pad” to “buffalo hump” as it is more descriptive and accurate 
medical terminology, while the latter potentially denigrates already the situation for the 
cosmetically-embarrassed or depressed patient.(Steel et al. 2006; Crane et al. 2008) Aside 
from dramatic changes in appearance leading to depression and social withdrawal, patients 
with dorsocervical fat pads may complain of headaches, difficulty with sleep, decreased 
range of motion, and an inability to fully extend the neck due to the physical size of the 
mass. 
There is general agreement in the medical community that liposuction is a safe and effective 
method of reducing the size of the dorsocervical fat pad.(Ponce-de-Leon et al. 1999; Piliero et 
al. 2003) The authors of this article have seen poor outcomes for many patients after 
attempted removal of the fat by direct surgical excision. The poor outcomes include only 
minimal reduction of the size of the fat pad while leaving long and unsightly scars. We have 
also seen suboptimal results in patients in which liposuction was performed in an effort to 
reduce the fat pads. One of the main reasons for the poor outcomes associated with 
liposuction of the dorsocervical fat pad is that these patients have all been placed in the 
prone position during the liposuction procedure. In the prone position, the dorsocervical fat 
pad recedes between the scapula and is harder to access. Neck extension in the prone 
position further anatomically distorts the cervical fat pads. This can be observed simply by 
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placement of the patient in the prone position and visibly noting the dorsal surface region. 
The dorsocervical fat is flattened and less demonstrable in the prone position as compared to 
the upright, anatomic position. Access is further impeded by the placement of the occiput in 
the prone position. The cephalad portions of the lesion are inaccessible to cannula insertion, 
rendering significant sections of the fat pad inoperable in the prone position. This is especially 
true for patients with lipodystrophic fat accumulation in the posterior neck and occipital scalp 
region, in which neck flexion is essential to cannula insertion. In this article, we propose an 
alternate positioning of the patient, which we feel gives far superior results. The patient is 
awake and seated in an upright position with the legs dangling off the edge of the operating 
table. With this technique, the surgeon stands behind the patient, allowing the surgeon greater 
access to all of the tissue. Having a patient awake allows his/her assistance in the positioning, 
providing a more complete removal of tissue and, therefore, a more successful outcome.  
 
 
Fig. 1. HIV infected man on HAART with a dorsocervical fat pad before and after 
lipoaspiration. A. Outlined dorsocervical fat pad prior to aspiration with black arrow 
pointing to parotid hypertrophy, B. Outlined dorsocervical fat pad with incision circles prior 
to aspiration with black arrow pointing to parotid hypertrophy, C. Postsurgical resolution of 
parotid hypertrophy and improved dorsocervical fat pad, D. Much improved dorsocervical 
fat pad and parotid hypertrophy (arrow). 
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Physical examination of the dorsocervical fat pad 
Physical examination of the patient with a dorsocervical fat pad reveals a fatty tissue 
buildup on the upper back which can be generally categorized as small, medium, large and 
extreme. There is no measurement guide to enable classification into these size categories. 
The fat accumulation in the dorsocervical area is subcutaneous and causes no changes to the 
skin itself, therefore, the overlying skin appears normal. Palpation reveals fat pads that are 
rather discrete, firm and immobile (unlike lipomas). Palpation often reveals that these 
masses extend into the posterior neck and nuchal regions of the occipital scalp. (Figure 1)  
Extension into the posterior neck and scalp deforms the normal dorsocervical angle and 
imparts a somewhat equine appearance to the neck. Rarely is there any pain associated with 
palpation, although patients report symptoms caused by these fat pads such as difficulty 
lying down, interference with sleep, and pain radiating to the shoulders and arms. Social 
withdrawal symptoms may be present, especially for patients with large, noticeable fat 
pads. These lesions are usually so characteristic, that it is not necessary to get any kind of 
diagnostic or radiographic confirmation with computed tomography (CT) or magnetic 
resonance imaging (MRI). 
3.2 Novel method for liposuction of the dorso-cervical fat pad  
The patient is prepared for local, tumescent liposuction in the pre-operative area. While in 
the pre-operative room the patient disrobes and puts on a hospital gown. Photographs are 
taken with the patient’s back to the camera in silhouette to document the pre-operative size 
and location. With the patient in a seated position, and legs dangling off the edge of the 
exam table, the entire back and posterior neck are cleaned with alcohol. The peripheral 
border of the dorsocervical fat pad is outlined with a pen in a continuous line (Figure 1). 
Five small circles are made approximately 2 cm from the outer boundary of the fat pad in a 
clockwise manner at 1, 4, 6, 8 and 11 o’clock although this may vary slightly per patient 
(Figure 1B; Figure 2B). These are the entrance points for both the infusion and suction 
cannulae. Ordinarily five incision sites (ports) are used but for smaller fat pads, three may 
be sufficient. Each of the circled sites is injected with 1 cc of lidocaine 1% and epinephrine 
1:100,000. The patient is pre-medicated with hydrocodone 5 mg and alprazolam 0.5 mg by 
mouth for pain and anxiety relief, and with lincomycin 600 mg I.M. for antibiotic 
prophylaxis. 
The patient is then escorted into the operating room and instructed to sit on the edge of the 
operating table allowing the surgeon to position him/herself behind the patient (Figure 2A, 
2C). During the surgery, the patient’s vital signs are continuously monitored using pulse 
oximetry, sphygmomanometry and electrocardiography. A medical stand with pillow is 
placed in front of the patient to lean on for support. The patient is prepped and gowned in a 
standard sterile fashion. The surgeon makes 3 mm incisions into the previously anesthetized 
peripheral circular sites using a #11-blade surgical scalpel. Tumescent fluid consisting of 
lidocaine and epinephrine buffered with sodium chloride (see below) is infiltrated liberally 
throughout the entire fat pad and allowed to sit for 15 to 30 minutes in order to achieve 
maximal vasoconstrictive effect.  
The tumescent fluid is prepared in the operative suite as follows: 1-2 vials of 50 mL lidocaine 
1% and epinephrine 1:100,000 and 10 cc of sodium bicarbonate 8.4% are added to 1,000 mL 
of 0.9% saline solution. Using two 50 mL vials of Lidocaine 1% and epinephrine 1:100,000 
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results in a lidocaine concentration of 0.1%. Infusing 1,000 to 1,500 cc allows for adequate 
tumescence without undue risk of lidocaine toxicity.  
Using a 3 mm Becker, or similar cannula, thorough and meticulous liposuction is carried out 
using all 5 of the peripheral incisions points (ports) employing a crisscross pattern over the 
entire expanse of the fat pad. The cannula is shifted every 16th of an inch angling up and 
over the entire breadth of the fat pad. For example, lipoaspiration will begin horizontal at 
the 6 o’clock port each time angling a 16th of an inch in a more vertical position going up and 
down, to and fro until the 12 o’clock position then working down on the opposite side again 
shifting every 16th of an inch. This same method is used at all incision sites. The neck and the 
occipital scalp can be accessed using these same incision sites provided a cannula of 
sufficient length is used (Figure 2E). 
 
 
Fig. 2. HIV infected man undergoing apiration for dorsocervical fat pad. A. The patient was 
placed in the sitting position with his feet dangling over the edge of the bed with a pillow 
rest, B. The dorsocervical fat pad is outlined as are the incision ports, C. The surgeon is able 
to stand straight up during the aspiration procedure, D. The patient participates in the 
procedure by flexing the neck, E. The surgeon is able to access all of the dorsocervical fat 
pad with the assistance of the patient. 
During the procedure the patient is asked to bend at the waist when the more cephalad 
parts of the dorsocervical fat pad are being aspirated and when the surgeon is using the 
superior ports. The patient position on the table can be angled at any time using the help of 
an assistant to make the suction more effective and comfortable to the surgeon and to 
remove as much tissue as possible to avoid recurrence. The patient’s head may also be bent 
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in a flexed position when suctioning the lesions that extend more superiorly into the 
posterior neck, occipital and post auricular scalp regions (Figure 2D, 2E).  
The fat entering the suction tubing from the dorsocervical fat pad appears yellow in color, 
although some admixture of blood is common. When the fat pad becomes flattened, the 
aspiration phase is over. The incision sites are closed using #5-0 nylon sutures, 
approximately two sutures per site. Antibiotic ointment and sterile dressings are applied to 
the incision sites. The patient is transferred to the post-anesthesia care unit (PACU) where 
vital sign monitoring is continued. Compression garments are not usually necessary, but the 
surgeon may recommend them for larger fat pads (25 cm in size and/or situated high onto 
the posterior head). The patient is discharged after 30 minutes of observation to the care of a 
family member or friend, at the discretion of the surgeon. Because patients have been pre-
medicated with sedatives, they are not allowed to drive themselves home. 
After discharge, the patient returns home and is asked to generally rest for 1-2 days. The 
patient may shower after 2 days and engage in their activities of daily living at this time 
except for those activities requiring rigorous physical effort such as running or weight-
lifting. The sutures are removed after five days and no dressings are generally needed after 
this time. Exercise can generally be resumed in one week. Patients follow-up in one month 
and are usually discharged from the office at that time. 
3.3 Outcomes after dorsocervical fat pad lipoaspiration of the awake patient 
In a recent detailed survey by the authors of one woman and eighteen men with an average 
age of 52±1.8 (mean±sem) years seeking lipoaspiration treatment for HIV-related 
dorsocervical fat pad, prior to surgery, on a scale of 0-5, five being very affected, 3 being 
somewhat affected, 1 being a little affected, and zero being not affected, patients felt their 
appearance was very affected (4.8±0.1), they experienced discomfort (3.5±0.4), their lives 
were changed somewhat due to the dorsocervical fat pad (3.7±0.4), they had some 
depression (3.4±0.4) and social withdrawal (3.6±0.4), the fat pad interfered a little, to 
somewhat during sleep (2.7±0.5), and their posture was somewhat to very affected (3.8±0.4). 
Within a year after lipoaspiration, by paired student’s t-test, there was a 82.1±6.2% 
improvement in appearance (average rating 0.9±0.3; P<0.0001), a 76.3±7.9% improvement in 
discomfort (0.4±0.1; P<0.0001), a 54.4±12.6% improvement in how their lives were changed 
by the dorsocervical fat pad (1.4±0.25 P=0.0006), a 72.9±7.5% improvement in feelings of 
depression (0.7±0.3; P<0.001), a significant 81.9±6.3% improvement in social withdrawal 
(0.5±0.2; P<0.0001), a significant decrease of 59.7±10.2% in sleep disturbance (0.3±0.1; 
P=0.0001) and a 61.1±10% improvement in posture (1.3±0.4; P=0.006). Eighteen of the 
patients graded the procedure as completely successful (5/5) and one graded the procedure 
as 4/5. One person had an infection after the procedure, one had slight pigmentation at the 
site of the scar and one felt the area was lumpy (2.5/5). On a scale of none (0), to moderate 
(2-3) to significant (5), patients rated swelling after the procedure at 2.7±0.3, bruising at 
2.0±0.3, and discomfort at 2.6±0.4. These data suggest excellent effectiveness of this novel 
procedure and impressive patient satisfaction and improvement in their quality of life. 
4. HIV-related parotid hypertrophy  
4.1 Background 
The most common HIV-associated salivary gland condition relates to the parotid glands. 
Originally described in 1985,(Ryan et al. 1985) HIV-associated salivary gland disease affects 
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1-5% of the infected population(Shanti and Aziz 2009; Schiodt et al. 1989) and usually 
involves diffuse enlargement of both parotid glands, known as bilateral parotid 
hypertrophy, although unilateral involvement has been seen. Also known as HIV-associated 
lymphoepithelial cysts of the parotid gland, they can occur as the initial manifestation of 
HIV infection or at any stage of the disease. (Shanti and Aziz 2009) While bilateral 
enlargement is most common, patients with unilateral hypertrophy are also seen.(Tao and 
Gullane 1991; Ortega et al. 2008)  Patients present with a bulging or widening of the lateral 
cheek area, sometimes giving a chipmunk cheek-like appearance. (Figure 3A) The degree of 
enlargement varies widely from patient to patient, from a barely discernable widening of 
the cheek, to an extremely large and disfiguring effect. Facial wasting is common in patients 
with parotid hypertrophy and generally accentuates the enlarged appearance of the glands.  
Histologically, the enlarged parotid is characterized by a marked squamous epithelium-
lined cystic dilation of the salivary glands surrounded by a lymphoid hyperplasia 
containing enlarged germinal centers.(Tao and Gullane 1991) Other salivary glands can also 
be enlarged by uniform follicular hyperplasia or reactive lymphadenopathy with follicular 
hyperplasia.(Shugar et al. 1988; Rosenberg et al. 1992) A diffuse form of salivary gland 
enlargement can also occur that is characterized histologically by atrophy of the gland 
parenchyma, lymphocytic infiltration, and replacement of ducts by solid islands of epithelial 
and myoepithelial cells.(Heymsfield et al. 1990) While patients rarely have overt symptoms 
due to gland enlargement, gland hypoplasia can occasionally lead to obstruction of the 
salivary duct and dryness of the mouth that mimics Sjögren’s syndrome.(Schiodt et al. 1992) 
Rarely, patients report tenderness to touch. (Mandel and Surattanont 2002) Once the parotid 
gland is enlarged, it tends to persist in size, rarely decreasing.(Schiodt et al. 1992) 
Many patients with parotid hypertrophy seek care because of a desire for cosmetic 
improvement especially when the glands are disfiguring. These patients may become 
reclusive and exhibit other social withdrawal types of behavior; depression is not 
uncommon. (Beitler et al. 1999)  
Prior to the procedure to lipoaspirate the hypertrophied parotid gland as described in this 
chapter, it is important that the surgeon consult with the patient’s primary care physician 
often in consultation with an ear, nose and throat (ENT) surgeon to rule out parotid 
hypertrophy due to HIV from other etiologies including bacterial infection with 
mycobacterium or pneumococcus,(Hanekom et al. 1995) viral infections with paramyxovirus 
(mumps)(McQuone 1999), autoimmune disease such as with Sjögren’s syndrome and rare 
manifestations including cancers such as carcinoma, Kaposi’s sarcoma(Burket et al. 2008), 
bilateral Warthin’s tumors, bilateral cystic pleomorphic adenomas,(Som et al. 1995) or 
lymphoma,(Wotherspoon and Isaacson 1996)sarcoidosis, necrotic intraparotid lymph nodes 
and bilateral first branchial cleft cysts (intraparotid).(Michelow et al., 2011) Evaluation of the 
parotid gland may include imaging such as CT or MRI.(Chapnik et al. 1990) 
4.2 Treatment options for parotid hypertrophy 
The options to reduce the size of the parotids in HIV-positive patients are: 1) direct surgical 
excision with a high rate of recurrence; 2) radiation therapy; and 3) a modification of a 
liposuction technique as described in this chapter. It is the experience of the authors that 
direct surgical excision and radiation therapy are fraught with complications and often have 
a high rate of recurrence. Complications of direct surgical excision include those associated 
with general anesthesia, infection and fistula formation. Radiation therapy complications 
include the loss of taste, dryness of the mouth, thrush and radiation dermatitis. Although 
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rare, formation of malignant tumors can occur, usually ten years out from radiation 
treatment using higher dose treatment modalities.(Beitler et al. 1999)  It is the experience of 
the authors that the most favorable outcome results from using a tumescent liposuction 
technique that successfully reduces the size of the parotids to a normal appearance without 
resultant complications. (see Methodology)   
4.3 Physical examination of the parotid glands 
Physical examination reveals a patient with discernable enlargement of the lateral cheeks. 
Palpation allows the parotid gland to be easily appreciated. The size of the parotid 
hypertrophy varies from patient to patient but is generally felt just anterior to the tragus of 
the ear extending inferiorly and wrapping around the earlobe crease near the 
sternocleidomastoid muscle. Sometimes the parotid may feel like a hypertrophied masseter 
muscle but it is the wrapping of the parotid around the earlobe crease that differentiates the 
enlarged parotid from muscle. It is also important to note that palpation is of the superficial 
aspect of the gland. The deeper portions of the gland that envelop the facial nerve cannot be 
palpated. While the enlarged glands are usually not tender, care should be taken on initial 
palpation as occasionally, some of the glands are tender to touch.  
4.4 Methodology for suction-assisted partial parotidectomy 
The patient is prepared for local, tumescent liposuction in the pre-operative area. While in 
the pre-operative room the patient disrobes and puts on a hospital gown. Photographs are 
taken with the patient facing the camera and in silhouette to document the pre-operative 
size and location. After photography, the patient is placed in a supine position and the 
entire face and neck are cleaned with alcohol. The peripheral border of the hypertrophied 
parotid gland is outlined with a pen in a continuous line and the incision sites are marked 
on the sideburn and on the earlobe crease. Depending on how far down the gland extends, a 
third incision site may be placed anterior to the sternocleidomastoid muscle. Each of the 
circled sites is injected with 1 cc of lidocaine 1% and epinephrine 1:100,000. The same 
procedure is repeated on the other side immediately after. The patient is then pre-medicated 
with hydrocodone 5 mg and alprazolam 0.5 mg by mouth for pain and anxiety relief, and 
lincomycin 600 mg I.M. for antibiotic prophylaxis. 
The pre-treated patient is brought to the operating room and placed in a supine position and 
prepped and draped in a sterile manner. Tumescent solution is very slowly infiltrated with a 
small diameter 1-2mm infiltration cannula throughout the entire parotid gland. 
Approximately 100cc of tumescent fluid is used on each side. Both glands are treated during 
the same surgical session. After the tumescent fluid is infused, a suction-aspiration 
technique using 2-3 mm cannulas with an aggressive tip is used to suction the lateral aspect 
of the parotid (Figure 3B). Generally shorter length cannulas are used with the parotids to 
gain better suction control. Parotid tissue can be seen entering the suction tubing as white 
fleshy tissue with a wet tissue appearance. Occasionally this tissue is often intermixed with 
yellow fat, tumescent fluid and blood if patients with lipodystrophy have infiltration of fat 
into the parotid gland. The patient is asked to turn his/her head when needed to facilitate 
access to the glands to be aspirated (Figure 3C). The surgeon’s to-and-fro motions are to be 
continued until it is felt that enough superficial glandular tissue has been removed to restore 
a normal appearance to the lateral face. During this procedure, we again note that only the 
superficial part of the parotid is removed. When suctioning over the anterior portion of the 
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check, it is important to maintain a superficial position in order not to compromise the 
integrity of the facial nerve. Many patients in conjunction with parotid hypertrophy have 
submental fat accumulation. Removal of the parotid gland is often combined with a 
submental fat aspiration during the same procedure. 
Generally, no sutures are needed and the incision sites are left open to heal spontaneously. 
This allows for drainage of the tumescent fluid and generally prevents hematoma and 
seroma formation. All patients receive a universal chin compression garment in the 
operating room and afterwards, the patient is transferred to the PACU. In place of a 
compression garment, an ace bandage may also be used. All compression should include the 
submental aspect of the neck. After approximately one hour of observation, patients are 
discharged to the care of a responsible family member or friend; the patient is never allowed 
to drive home.  
During the recovery period, the patient and usually rests for 4-5 days at home while 
continuously wearing the compression garment. The patient returns to the office for a 
follow-up visit at which time the patient is examined for possible infection, hematomas, 
seromas, etc. The patient may resume activities of daily living at this time except for those 
that require rigorous physical effort. Exercise can generally be resumed in 2-3 weeks 
depending on the patient’s signs and symptoms such as tenderness, swelling and bruising 
which are common following surgery of the head and neck is common. It is recommended 
that symptoms completely resolve before resuming any strenuous activity especially heavy 
lifting and running.  
 
 
Fig. 3. Surgical lipospiration technique for parotid hypertrophy in HIV-infected men on 
HAART. A. Pre-surgical parotid hypertrophy, B. Post-surgical resolution of parotid 
hypertrophy, C. Angling techniques enabled by awake positioning of the patient. 
4.5 Outcomes after parotid lipoaspiration 
In a recent detailed survey by the authors of one woman and eleven men with an average 
age of 53.5±2 years seeking lipoaspiration treatment for parotid hypertrophy, three had 
prior radiation treatment, two had previous surgery and two had both previous radiation 
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and surgery. Prior to surgery, on a scale of 0-5, five being very affected, 3 being somewhat 
affected, 1 being a little affected, and zero being not affected, patients felt their appearance 
was very affected (4.65±0.2), they experienced discomfort (4.0±0.5), a significant change in 
their lives due to the parotid hypertrophy (4.3±0.4), some depression (3.9±0.4) and social 
withdrawal (3.9±0.4) and a little problem with chewing (1.4±0.4). Within a year after 
lipoaspiration, by paired student’s t-test, there was a 76.8±4.7% improvement in appearance 
(average rating 1.08±0.2; P<0.0001), a 69±8.6% improvement in discomfort (1.09±0.3; 
P<0.0001), a 72.5±7.9% improvement in how their lives were changed by parotid 
hypertrophy (1.08±0.2; P<0.0001), a 60±10% improvement in feelings of depression (1.5±0.3; 
P<0.001), a 73.9±5.4% improvement in social withdrawal (1.09±0.3; P<0.00001) and a 
45±12.5% improvement in chewing (0.9±0.1; P=0.006). After the surgery, two patients had 
minor infections at the surgical site, two patients continued to complain of xerostomia due 
to prior radiation with no new cases of xerostomia, one patient developed thrush, and four 
patients had some discoloration of the skin at the surgical incision sites. When asked about 
regrowth of the parotid tissue, ten had none and two had some regrowth. Nine of the 
patients graded the procedure as completely successful, two said it was somewhat 
successful and one graded the surgery in-between somewhat and completely successful. In 
a larger number of patients (n=72) treated with the tumescent suction technique under local 
anesthesia, follow-up questionnaires were obtained in 43 patients. In these 43 patients using 
a scale of 0 to 5, with 0 being ‘no success’ and 5 being ‘highly successful’, the rate of success 
was on average (±sem) 4.8±0.1. In this larger sampling of patients, there were no incidents of 
infection, no disturbance in chewing, no complaints of dry mouth and no incidents of 
recurrence at 3 year follow-up.  
5. Discussion 
HIV dorsocervical fat pad and HIV-related parotid hypertrophy are frequently seen in 
clinical practice. The use of novel liposuction techniques in the treatment of these conditions 
as described in this chapter are advances that result in better outcomes, i.e., better cosmetic 
results, lower recurrence rates and fewer complications than previously used techniques. 
With respect to HIV-related dorsocervical lipodystrophy, tumescent liposuction under 
general anesthesia, with the patient in the prone position has been shown to be effective, but 
recurrence is commonly seen, with only partial removal of tissue. It is reasonable to assume 
that optimal tumor clearance is essential, not only in creating an acceptable cosmetic 
outcome but also for maintaining long-term results. Due to the fibrous nature of these 
lesions, aspiration is typically difficult and more laborious as compared to aspiration of non-
dystrophic fat.(Davison et al. 2007)It is imperative for the surgeon to position him/herself 
with respect to the patient in a strategic manner that will facilitate optimal lesion 
visualization and rigorous cannula dissection while preserving comfort for both the surgeon 
and the patient. Working with an intubated patient under general anesthesia limits access to 
the superior portions of the fat pad and those portions in the posterior neck and scalp. For 
example, when the patient is lying prone under anesthesia, the mass of the dorsocervical fat 
pad tends to disappear between the scapulae making it difficult access the entire depth of 
the tissue. We can speculate that the high rate of recurrence may be due to incomplete tissue 
removal when the patient is in the prone position. We use standard liposuction procedures 
for suction of the fat pad but position the patient awake and upright with the surgeon 
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behind the patient. The patient participates by bending and twisting to allow for suction-
assisted removal of the maximum amount of tissue. With our method of positioning, the 
patient can round the shoulders exposing the mass of the tissue. This provides a better 
cosmetic result, improves patient satisfaction, and decreases the rate of recurrence. Having a 
cooperative awake patient also eliminates the complications of general anesthesia, which are 
well known. Since 1997, the authors have treated over 1400 patients with dorsocervical fat 
pads with the patients seated upright and awake. During this period of time, it appears that 
less than 10% of these patients have had a recurrence. Difficulty with patient follow-up, 
however, makes it impossible to be completely accurate with our statistics. 
With respect to lipoaspiration of the hypertrophied parotid gland, the goal of the parotid 
reconstructive procedure is to restore the patient to a more normal appearance; not to 
remove the entire gland. The procedure is limited to the removal of only that portion of the 
parotid lying superficial to the facial nerve. Local tumescent anesthesia achieves adequate 
anesthesia in all patients undergoing suction aspiration for parotid reduction. Using this 
procedure, our data suggest that patient satisfaction is high and quality of life is improved 
with minimal complications. Since the tissue being removed during the suction-assisted 
partial parotidectomy is not primarily fat, the procedure cannot technically be called 
liposuction. The authors suggest the term “glandular aspiration” or “adeno-suction” to 
more accurately characterize the operative procedure to reduce parotid size.  
We feel the novel positioning during our procedures with patients that are awake and 
participate in the procedure, should be the standard of care for HIV-related dorsocervical fat 
pad and parotid hypertrophy. We welcome other surgeons to replicate these procedures in a 
similar fashion and report their results so as to add to the general experience with these 
procedures. Our hope is that improvements can be made based on the work we have 
accomplished to date. 
5.1 ICD-9 and CPT Coding 
An important issue for patients relates to insurance reimbursement for the correction of 
HIV-lipodystrophy and parotid hypertrophy. Using standard liposuction codes (15887 
liposuction, truncal and 15886 liposuction, facial) are met with consistent denials from 
insurance companies as these codes imply procedures performed for cosmetic purposes. 
Insurance carriers understandably do not reimburse for cosmetic procedures such as 
liposuction performed to eliminate “love handles” or abdominal fat to provide a trimmer 
waistline. However, the conditions as described in this chapter are clearly reconstructive as 
they are intended to correct a deformity caused by a disease. State health and safety codes 
clearly define the difference between cosmetic and reconstructive procedures (e.g., 
California Health and Safety Code Section 1367.22). Although during the procedures, the 
equipment and techniques are the same as in cosmetic liposuction, we feel it is justified to 
code these procedures for reimbursement of HIV lipodystrophy and HIV partial 
parotidectomy as partial excisions, excisions and radical excisions as appropriate to the 
individual patient (refer to Table 1 for guidance in diagnostic and procedure coding 
decisions). We hope the health insurance industry can broaden their understanding of the 
damaging effects of people living with HIV lipodystrophy and parotid hypertrophy and 
reimburse as they would for other reconstructive procedures such as breast reconstruction 
following mastectomy or cleft palate surgery 
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CPT Code Description 
21555 Excision, tumor, soft tissue of neck or anterior thorax, subcutaneous; 3 cm 
21557 Radical resection of tumor (e.g., malignant neoplasm), soft tissue of neck or 
anterior thorax; <5 cm 
21558 Radical resection of tumor (eg, malignant neoplasm), soft tissue of neck or 
anterior thorax; 5 cm or greater 
21930 Excision, tumor, soft tissue of back or flank, subcutaneous; 3 cm or greater 
21935 Radical resection of tumor (eg, malignant neoplasm), soft tissue of back or 
flank; 5 cm 
21936 Radical resection of tumor (eg, malignant neoplasm), soft tissue of back or 
flank; 5 cm 
42410 Excision of parotid tumor or parotid gland; lateral lobe, without nerve 
dissection (parotidectomy) 
 
2011 ICD-9 Description 
042 Human immunodeficiency virus (HIV) disease 
272.6 Lipodystrophy; a collection of rare conditions resulting from defective fat 
metabolism and characterized by atrophy of the subcutaneous fat; includes 
total, congenital or acquired, partial, abdominal infantile, and localized 
lipodystrophy. 
235 Parotid hypertrophy (neoplasm of uncertain behavior of major salivary 
glands) 
Table 1. Reimbursement codes for the surgical management of the HIV positive patient. 
6. Summary 
The main goal of lipoaspiration of the dorsocervical fat pad and parotid hypertrophy as part 
of HIV infection and HAART treatment is to improve patient outcomes and safety. It is also 
important to preserve the comfort of the surgeon while providing a cost effective procedure 
that is affordable by the patient and covered by insurance. These lipoaspiration procedures 
described here avoid general anesthesia and include the patient as a direct participant in the 
procedure to ensure maximal removal of adipose tissue in the dorsocervical fat pad, and 
accurate removal of glandular tissue in the case of parotid hypertrophy. Our experience in 
the use of these procedures is that patients rate their experience and satisfaction with the 
procedures as very high. 
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